Study Claims Ozempic Lowers Biological Age
Researchers reveal that GLP-1 medication Ozempic may reduce biological age, offering new hope in the fight against aging and related health issues.
Ozempic, originally developed as a treatment for diabetes, has proven to be versatile, with uses in treating obesity, promoting weight loss, and other conditions.
- Treating obesity and promoting weight loss
- Treating conditions associated with or impacted by obesity
A 32-week, double-blind, placebo-controlled trial by TruDiagnostic suggests that Ozempic may reduce the user’s biologic age by just over three years.
Ozempic may reduce biological age, offering new hope in the fight against aging and related health issues.
Author's summary: Ozempic reduces biological age.
More News
- US Weekly Headlines: Policy change for Pentagon officials, government shutdown continues
- Benz Hui Dies At 76 from Cancer-Related Organ Failure
- The Global Cleanergy Shift: A Watershed Moment for Investors () | aktiencheck.de
- The Tech Odyssey: AI, Moonshots, and Musk's Encyclopedia of Everything
- Biofuels and ethanol key to the future of U.S. agriculture - High Plains Journal
- GSK acquires exclusive rights from Syndivia for antibody drug conjugate in prostate cancer
- ASML Shares Surge as Artificial Intelligence Demand Fuels Record Performance () | aktiencheck.de
- Egyptian journalist Ismail Alexandrani held for past month - one month too many!
- The Coming Dementia Crisis—and the Cost of Doing Nothing
- Nigeria: Christian Genocide and the Dangers of Mischaracterisation